Psoria-Light
Tampa, Fla. manufacturer, Psoria?Shield Inc., has announced the launch of sales for its flagship medical device, the Psoria?Light (FDA 510k #K103540). The Psoria?Light is a Deep UV LED targeted phototherapy device for treating psoriasis, eczema, vitiligo and other UV?treatable skin disorders.
The Psoria?Light patent?pending innovation uses advanced Deep UV LED technology originally developed for NASA, ESA, and the U.S. military. Psoria?Light targeted UV phototherapy technology is exclusively recognized as a Certified Space Technology by the Space Foundation.
Psoria?Light offers the same narrow?band UVB light region, dosage and small treatment spot size as excimer laser?based targeted UV phototherapy devices. Psoria?Light delivers both NB?UVB and UVA light to treat skin disorders.
Psoria?Shield was established in 2009 with the goal of creating less toxic non?invasive treatment options for patients suffering from UV?treatable skin disorders. President and Founder Scot Johnson, a medical device design engineer, has been developing cutting?edge medical devices within the Tampa Bay area for over 16 years.
Psoria?Light is currently sold to dermatologists and qualified healthcare providers, but not for personal use at home. Targeted UV phototherapy generally facilitates clearance of skin conditions within 6 to 10 treatments, and up to five times faster than non?targeted UV phototherapy treatment currently available. Targeted UV phototherapy has only a local effect on the skin, and is a less toxic treatment option than many of the biologic and systemic treatments currently being utilized to treat psoriasis, eczema and vitiligo.
Dr. Seth Forman, a Tampa based dermatologist, will be the first in the Tampa Bay area to provide Psoria?Light treatment to his patients.
Patients interested in finding treatment in their area can visit: http://www.psoria?shield.com/how?get-psoria?light?treatment.
About Psoria?Shield: Psoria?Shield advocates the use of targeted UV phototherapy to address those aspects of patients� disease which reduce their Quality of Life the most, first. By addressing the major detractors from patients� Quality of Life initially, patients and healthcare providers can address the remaining regions of skin with less aggressive therapy.
Related to Psoria-Light:
If you enjoyed this post, please consider leaving a comment, subscribe to the feed and get future articles delivered to your feed reader or follow us on Twitter.
Comments for Psoria-Light
No comments yet.
Share Your Thoughts on Psoria-Light